COVID-19 Blog - Microbix

Microbix Presenting at Muskoka Capital Conference – 2023

Sep 29, 2023

Meetings with Growth-Oriented Investors, September 29 to October 1, 2023 MISSISSAUGA, CANADA, September 29, 2023 - Microbix Biosystems...

Sep 27, 2023

Over C$ 1 Million in Orders from Leading Diagnostics Industry Test-Maker MISSISSAUGA, CANADA, September 27, 2023 – Microbix Biosystems...

Sep 26, 2023

In this episode we're going to talk about current and emerging diagnostics technologies, how they're viewed by government leaders, and how...

Sep 13, 2023

Microbix Honours the Passing of its Founder William J. Gastle – 1948 to 2023 MISSISSAUGA, CANADA, September 13, 2023 – Microbix Biosystems...

Aug 10, 2023

Strong Sales of $5.5 million alongside Drug Partnering Agreement MISSISSAUGA, August 10, 2023 - Microbix Biosystems Inc. (TSX: MBX, OTCQX:...

Aug 7, 2023

Achieves “Go-Live” with New ERP and eQMS Solutions MISSISSAUGA, CANADA, August 4, 2023 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF,...

Jul 24, 2023

FLOQSwab-formatted QAPs Supporting Fourplex PCR Tests for Bacterial STIs MISSISSAUGA, CANADA, July 24, 2023 – Microbix Biosystems Inc....

Jul 5, 2023

Distribution Partner Secures Contract Relating to Cervical Cancer Screening MISSISSAUGA, CANADA, July 5, 2023 – Microbix Biosystems Inc....

Jun 20, 2023

So…you got your Respiratory infection test results back from the doctor. Should you trust them? Well, the answer is YES! Why? There is a...

Jun 20, 2023

https://microbix.com/wp-content/uploads/2022/05/ECCMID-2022-FINAL-March-29-2022.pdf